Evaluation of S100A8/A9 and neutrophils as prognostic markers in metastatic melanoma patients under immune-checkpoint inhibition
2024 · Translational Oncology · 5 citations
https://doi.org/10.1016/j.tranon.2024.102224
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
23
Citations
2
h-index
1
i10-index
Nadine L. Ammann is an academic researcher from Universität Hamburg. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & S100 Proteins and Annexins. The author has an h-index of 2, co-authored 6 publications.
ORCID: 0000-0002-2288-6258Click to start Chat